333 related articles for article (PubMed ID: 12575493)
1. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).
Saletu B; Anderer P; Saletu-Zyhlarz GM; Arnold O; Pascual-Marqui RD
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():97-120. PubMed ID: 12575493
[TBL] [Abstract][Full Text] [Related]
2. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs.
Saletu B; Anderer P; Saletu-Zyhlarz GM
Clin EEG Neurosci; 2006 Apr; 37(2):66-80. PubMed ID: 16733939
[TBL] [Abstract][Full Text] [Related]
3. Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging).
Saletu B; Anderer P; Kinsperger K; Grünberger J
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):385-408. PubMed ID: 2888937
[TBL] [Abstract][Full Text] [Related]
4. EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle.
Saletu B; Anderer P; Saletu-Zyhlarz GM; Pascual-Marqui RD
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():97-106. PubMed ID: 12575475
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
Herrmann WM; Schärer E; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative pharmaco-EEG study of nootropics].
Kinoshita T
Seishin Shinkeigaku Zasshi; 1990; 92(5):255-76. PubMed ID: 2119513
[TBL] [Abstract][Full Text] [Related]
8. The significance of pharmacodynamic measurements in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping.
Itil TM; Itil KZ
J Clin Psychiatry; 1986 Sep; 47 Suppl():20-7. PubMed ID: 3528132
[TBL] [Abstract][Full Text] [Related]
9. HZI systems for EEG parametrization and classification of psychotropic drugs.
Itil TM; Shapiro DM; Herrmann WM; Schulz W; Morgan V
Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):4-19. PubMed ID: 419164
[TBL] [Abstract][Full Text] [Related]
10. Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):449-59. PubMed ID: 21853
[TBL] [Abstract][Full Text] [Related]
11. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Herrmann WM; Schärer E; Wendt G; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
[TBL] [Abstract][Full Text] [Related]
12. Pharmaco-EEG in psychiatry.
Mucci A; Volpe U; Merlotti E; Bucci P; Galderisi S
Clin EEG Neurosci; 2006 Apr; 37(2):81-98. PubMed ID: 16733940
[TBL] [Abstract][Full Text] [Related]
13. [A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Suitsu N
Seishin Shinkeigaku Zasshi; 1992; 94(3):238-62. PubMed ID: 1589555
[TBL] [Abstract][Full Text] [Related]
14. Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEG.
Boeijinga PH; Calvi-Gries F; Demazières A; Luthringer R
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():17-26. PubMed ID: 12575484
[TBL] [Abstract][Full Text] [Related]
15. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects.
Saletu B; Grünberger J
J Clin Psychiatry; 1988 Aug; 49 Suppl():59-71. PubMed ID: 2970456
[TBL] [Abstract][Full Text] [Related]
16. EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principle.
Saletu B; Anderer P; Saletu-Zyhlarz GM; Pascual-Marqui RD
Clin EEG Neurosci; 2005 Apr; 36(2):108-15. PubMed ID: 15999906
[TBL] [Abstract][Full Text] [Related]
17. [The use of electrophysiological techniques to project typical psychotropic drug effects: some examples (author's transl)].
Herrmann WM; Kubicki S
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1981 Mar; 12(1):21-32. PubMed ID: 6112131
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
Saletu B; Grünberger J
Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
[TBL] [Abstract][Full Text] [Related]
19. Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples.
Barbanoj MJ; Riba J; Morte A; Antonijoan RM; Jané F
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():67-83. PubMed ID: 12575490
[TBL] [Abstract][Full Text] [Related]
20. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
